Literature DB >> 8448158

Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing.

N Stahl1, M A Baldwin, D B Teplow, L Hood, B W Gibson, A L Burlingame, S B Prusiner.   

Abstract

The only component of the infectious scrapie prion identified to date is a protein designated PrPSc. A posttranslational process converts the cellular PrP isoform (PrPC) into PrPSc. Denatured PrPSc was digested with endoproteases, and the resulting fragments were isolated by HPLC. By both mass spectrometry and Edman sequencing, the primary structure of PrPSc was found to be the same as that deduced from the PrP gene sequence, arguing that neither RNA editing nor protein splicing feature in the synthesis of PrPSc. Mass spectrometry also was used to search for posttranslational chemical modifications other than the glycosylinositol phospholipid anchor attached to the C-terminus and two Asn-linked oligosaccharides already known to occur on both PrPSc and PrPC. These results contend that PrPSc molecules do not differ from PrPC at the level of an amino acid substitution or a posttranslational chemical modification; however, we cannot eliminate the possibility that a small fraction of PrPSc is modified by an as yet unidentified posttranslational process or that PrPC carries a modification that is removed in the formation of PrPSc. It seems likely that PrPSc differs from PrPC in its secondary and tertiary structure, but the possibility of a tightly bound, disease-specific molecule which purifies with PrPSc must also be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448158     DOI: 10.1021/bi00059a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  136 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.

Authors:  S Supattapone; H O Nguyen; T Muramoto; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

4.  Location and properties of metal-binding sites on the human prion protein.

Authors:  G S Jackson; I Murray; L L Hosszu; N Gibbs; J P Waltho; A R Clarke; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

6.  Computational studies on prion proteins: effect of Ala(117)-->Val mutation.

Authors:  Noriaki Okimoto; Kazunori Yamanaka; Atsushi Suenaga; Masayuki Hata; Tyuji Hoshino
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

7.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

8.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

9.  One O-linked sugar can affect the coil-to-beta structural transition of the prion peptide.

Authors:  Pei-Yeh Chen; Chun-Cheng Lin; Yin-Ting Chang; Su-Ching Lin; Sunney I Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

10.  Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.

Authors:  K Kaneko; D Peretz; K M Pan; T C Blochberger; H Wille; R Gabizon; O H Griffith; F E Cohen; M A Baldwin; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.